What's new

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 16, Status: Authorised

Jun 20, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Virtual live hands-on training course for clinical trials sponsors using EudraVi...

Next Article

Human medicines European public assessment report (EPAR): Colobreathe, colistime...

Related Posts

Human medicines European public assessment report (EPAR): Afiveg, aflibercept, Status: Opinion

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0

Human medicines European public assessment report (EPAR): Supemtek Tetra (previously Supemtek), quadrivalent influenza vaccine (recombinant, prepared in cell culture), Date of authorisation: 16/11/2020, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

May 22, 2025  0

EMEA-003394-PIP01-23

EMEA-003394-PIP01-23

Jun 5, 2025  0